BORGHESI, MARCO
 Distribuzione geografica
Continente #
EU - Europa 7.537
AS - Asia 1.560
NA - Nord America 1.304
Continente sconosciuto - Info sul continente non disponibili 206
SA - Sud America 115
AF - Africa 15
OC - Oceania 4
Totale 10.741
Nazione #
IT - Italia 7.293
US - Stati Uniti d'America 1.198
SG - Singapore 522
CN - Cina 518
VN - Vietnam 201
BD - Bangladesh 180
FR - Francia 135
BR - Brasile 74
HK - Hong Kong 53
CA - Canada 37
FI - Finlandia 23
AR - Argentina 17
CH - Svizzera 17
DE - Germania 15
JM - Giamaica 14
MX - Messico 14
GB - Regno Unito 12
IN - India 12
ID - Indonesia 11
JP - Giappone 11
PH - Filippine 10
CR - Costa Rica 9
NL - Olanda 9
HN - Honduras 8
CO - Colombia 7
EC - Ecuador 6
IQ - Iraq 6
TH - Thailandia 6
ES - Italia 5
DZ - Algeria 4
GT - Guatemala 4
MA - Marocco 4
MY - Malesia 4
NI - Nicaragua 4
AE - Emirati Arabi Uniti 3
AT - Austria 3
AU - Australia 3
BB - Barbados 3
BE - Belgio 3
CZ - Repubblica Ceca 3
IE - Irlanda 3
PE - Perù 3
PK - Pakistan 3
PY - Paraguay 3
RU - Federazione Russa 3
SI - Slovenia 3
SV - El Salvador 3
TW - Taiwan 3
UZ - Uzbekistan 3
VE - Venezuela 3
IL - Israele 2
JO - Giordania 2
KG - Kirghizistan 2
PA - Panama 2
PR - Porto Rico 2
RO - Romania 2
SA - Arabia Saudita 2
SN - Senegal 2
TN - Tunisia 2
TR - Turchia 2
XK - ???statistics.table.value.countryCode.XK??? 2
AL - Albania 1
AW - Aruba 1
BG - Bulgaria 1
BS - Bahamas 1
CL - Cile 1
DM - Dominica 1
DO - Repubblica Dominicana 1
GR - Grecia 1
KE - Kenya 1
KH - Cambogia 1
LC - Santa Lucia 1
LT - Lituania 1
LY - Libia 1
NP - Nepal 1
PG - Papua Nuova Guinea 1
PS - Palestinian Territory 1
RS - Serbia 1
SE - Svezia 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
UA - Ucraina 1
UY - Uruguay 1
ZA - Sudafrica 1
Totale 10.537
Città #
Genoa 3.148
Genova 2.307
Vado Ligure 958
Rapallo 698
San Jose 319
Singapore 162
Lauterbourg 127
New York 97
Ashburn 87
Beijing 68
Ho Chi Minh City 61
Hong Kong 51
Hanoi 47
Milan 28
Los Angeles 26
Santa Clara 26
Helsinki 23
St Louis 22
Buffalo 20
Chicago 20
Rome 19
Dallas 18
Tianjin 18
Council Bluffs 16
Zurich 15
Frankfurt am Main 14
Bordighera 11
Atlanta 10
Phoenix 10
Tokyo 10
Haiphong 9
Kingston 9
Mexico City 9
Amsterdam 8
Da Nang 8
Toronto 8
Washington 8
San José 7
São Paulo 7
Catania 6
Las Vegas 6
Montreal 6
Philadelphia 6
Shanghai 6
Cagliari 5
City of London 5
Columbus 5
Houston 5
Naples 5
Pasadena 5
Queens 5
San Francisco 5
Turin 5
Beloit 4
Boardman 4
Brooklyn 4
Greenville 4
Guayaquil 4
Holden 4
Hải Dương 4
Newark 4
North Little Rock 4
Palermo 4
Portland 4
Princeton 4
San Diego 4
Seattle 4
Thái Bình 4
Baghdad 3
Biên Hòa 3
Bologna 3
Brasília 3
Brescia 3
Bridgetown 3
Brno 3
Charleston 3
Charlotte 3
Concord 3
Dubai 3
Dublin 3
El Progreso 3
Florence 3
Guangzhou 3
Guatemala City 3
Jackson 3
Lexington 3
Ljubljana 3
Louisville 3
Managua 3
Medford 3
Orem 3
Orlando 3
Padua 3
Peoria 3
San Antonio 3
Tampa 3
Tashkent 3
The Bronx 3
Winnipeg 3
Xi'an 3
Totale 8.740
Nome #
Treatment paths for localised prostate cancer in Italy: The results of a multidisciplinary, observational, prospective study (Pros-IT CNR) 170
A prospective, multicenter evaluation of predictive factors for positive surgical margins after nephron-sparing surgery for renal cell carcinoma: The record1 italian project 163
Predicting survival in node-positive prostate cancer after open, laparoscopic or robotic radical prostatectomy: A competing risk analysis of a multi-institutional database 155
Can side-specific biopsy findings predict the side of nodal metastasis in clinically localized prostate cancer? Results from a multicenter prospective survey. 150
Evaluating the predictive accuracy and the clinical benefit of a nomogram aimed to predict survival in node-positive prostate cancer patients: External validation on a multi-institutional database 143
A snapshot of nephron-sparing surgery in Italy: A prospective, multicenter report on clinical and perioperative outcomes (the RECORd 1 project) 134
Laparoscopic and robotic ureteral stenosis repair: a multi-institutional experience with a long-term follow-up 121
Role of Clinical and Surgical Factors for the Prediction of Immediate, Early and Late Functional Results, and its Relationship with Cardiovascular Outcome after Partial Nephrectomy: Results from the Prospective Multicenter RECORd 1 Project 103
3D reconstruction and physical renal model to improve percutaneous punture during PNL 103
The impact of sars-cov-2 pandemic on time to primary, secondary resection and adjuvant intravesical therapy in patients with high-risk non-muscle invasive bladder cancer: A retrospective multi-institutional cohort analysis 101
18F-FACBC compared with 11C-choline PET/CT in patients with biochemical relapse after radical prostatectomy: A prospective study in 28 patients 98
An increased body mass index is associated with a worse prognosis in patients administered BCG immunotherapy for T1 bladder cancer 94
Survival after radical prostatectomy vs. radiation therapy in ductal carcinoma of the prostate 92
Can testis-sparing surgery for small testicular masses be considered a valid alternative to radical orchiectomy? A prospective single-center study 92
Adverse Features and Competing Risk Mortality in Patients With High-Risk Prostate Cancer 91
Survival after radical prostatectomy versus radiation therapy in clinical node-positive prostate cancer 90
Bladder cancer histological variants: which parameters could predict the concordance between transurethral resection of bladder tumor and radical cystectomy specimens? 89
Are Urologists Ready for Interpretation of Multiparametric MRI Findings? A Prospective Multicentric Evaluation 87
PADUA and R.E.N.A.L. nephrometry scores correlate with perioperative outcomes of robot-assisted partial nephrectomy: analysis of the Vattikuti Global Quality Initiative in Robotic Urologic Surgery (GQI-RUS) database 87
Differing risk of cancer death among patients with lymph node metastasis after radical prostatectomy and pelvic lymph node dissection: Identification of risk categories according to number of positive nodes and Gleason score 84
The Intraoperative Complications Assessment and Reporting with Universal Standards (ICARUS) Global Surgical Collaboration Project: Development of Criteria for Reporting Adverse Events During Surgical Procedures and Evaluating Their Impact on the Postoperative Course 84
11C-Choline PET/CT in castration-resistant prostate cancer patients treated with docetaxel 84
Systemic Inflammatory Markers and Oncologic Outcomes in Patients with High-risk Non–muscle-invasive Urothelial Bladder Cancer 83
Nomogram for predicting the likelihood of postoperative surgical complications in patients treated with partial nephrectomy: a prospective multicentre observational study (the RECORd 2 project) 83
Clinically localized renal cell carcinoma: Which is the best treatment strategy? 82
A new preperitoneal technique for the repair of inguinal hernia during prostatic surgery: First 153 procedures 82
How Can the COVID-19 Pandemic Lead to Positive Changes in Urology Residency? 82
Blood donors: An ideal population to study the PSA value and the incidence of prostate cancer in healthy population 80
Robot-assisted partial nephrectomy: Excellent results even in more complex renal tumours 79
Re: Long-term outcomes of patients with lymph node metastasis treated with radical prostatectomy without adjuvant androgen-deprivation therapy 79
Prediction nomogram for 68Ga-PSMA-11 PET/CT in different clinical settings of PSA failure after radical treatment for prostate cancer 79
Association of statin use and oncological outcomes in patients with first diagnosis of T1 high grade non-muscle invasive urothelial bladder cancer: results from a multicenter study 78
68Ga-PSMA-PET/CT-guided salvage retroperitoneal lymph node dissection for disease relapse after radical prostatectomy for prostate cancer 77
Long-term evaluation of survival, continence and potency (SCP) outcomes after robot-assisted radical prostatectomy (RARP) 77
Effect of inguinal lymph node dissection in lymph node negative patients with squamous cell carcinoma of the penis 76
18F-Fluciclovine PET/CT for the Detection of Prostate Cancer Relapse: A Comparison to 11C-Choline PET/CT 76
Nodal occult metastases in intermediate- and high-risk prostate cancer patients detected using serial section, immunohistochemistry, and real-time reverse transcriptase polymerase chain reaction: Prospective evaluation with matched-pair analysis 76
What is the standard surgical approach to large volume BPE? Systematic review of existing randomized clinical trials 76
Immuno-oncology therapy in metastatic bladder cancer: A systematic review and network meta-analysis 76
Diagnostic accuracy of 11C-choline PET/CT in preoperative lymph node staging of bladder cancer: A systematic comparison with contrast-enhanced CT and histologic findings 75
Absolute basophil count is associated with time to recurrence in patients with high-grade T1 bladder cancer receiving bacillus Calmette–Guérin after transurethral resection of the bladder tumor 74
First case of 18F-FACBC PET/CT-guided salvage radiotherapy for local relapse after radical prostatectomy with negative 11C-Choline PET/CT and multiparametric MRI: New imaging techniques may improve patient selection 74
The role of multiparametric MRI in active surveillance for low-risk prostate cancer: The ROMAS randomized controlled trial 74
Small renal masses managed with active surveillance: Predictors of tumor growth rate after long-term follow-up 73
Active surveillance for clinically localized renal tumors: An updated review of current indications and clinical outcomes 73
Laparoscopic radical prostatectomy: 10 years of experience at a single institution 73
Can the multiphasic computed tomography be useful in the clinical management of small renal masses? 73
Urology in the Time of Coronavirus: Reduced Access to Urgent and Emergent Urological Care during the Coronavirus Disease 2019 Outbreak in Italy 73
Radical cystectomy in non-metastatic sarcomatoid bladder cancer: A direct comparison vs urothelial bladder cancer 72
An isolated penile mass in a young adult turned out to be a primary marginal zone lymphoma of the penis. A case report and a review of literature 72
Innovative 3D method predicts surgery outcomes by calculating real contact surface of renal tumor 71
The number of nodes removed as well as the template of the dissection is independently correlated to cancer-specific survival after radical cystectomy for muscle-invasive bladder cancer 71
Survival after Radical Prostatectomy versus Radiation Therapy in High-Risk and Very High-Risk Prostate Cancer 70
Lymphovascular invasion in high grade T1 bladder cancer: Are more aggressive treatments needed? 69
Editorial Comment from Dr Schiavina and Dr Borghesi to Postoperative prostate-specific antigen monitoring interval for radical prostatectomy patients with low recurrence risk 68
Diagnostic imaging work-up for disease relapse after radical treatment for prostate cancer: How to differentiate local from systemic disease? The urologist point of view 68
First case of F-FACBC PET/CT-guided salvage retroperitoneal lymph node dissection for disease relapse after radical prostatectomy for prostate cancer and negative 11C-Choline PET/CT: New imaging techniques may expand pioneering approaches 68
Overall Survival of Metastatic Prostate Cancer Patients According to Location of Visceral Metastatic Sites 67
Inguinal canal tumors of adulthood 67
Active surveillance for small renal masses diagnosed in elderly or comorbid patients: Looking for the best treatment strategy [Vigilancia activa de masas renales pequeñas diagnosticadas en pacientes de edad avanzada o con comorbilidad: en busca de la mejor estrategia de tratamiento] 67
Robot-assisted radical nephroureterectomy for upper urinary tract urothelial carcinoma: A promising alternative to open surgery or a future "Gold Standard"? 67
Immunohistochemical Prostate-specific Membrane Antigen (PSMA) Expression Patterns of Primary Prostate Cancer Tissue as a Determining Factor for Prostate Cancer Staging with PSMA Positron Emission Tomography/Computed Tomography 66
Posterior muscolofascial reconstruction incorporated into urethrovescical anastomosis during robot-assisted radical prostatectomy 66
Diagnostic performance of MRI/TRUS fusion-guided biopsies vs. systematic prostate biopsies in biopsy-naïve, previous negative biopsy patients and men undergoing active surveillance 66
Indication for and extension of pelvic lymph node dissection during robot-assisted radical prostatectomy: An analysis of five European institutions 65
The Role of mpMRI in the Assessment of Prostate Cancer Recurrence Using the PI-RR System: Diagnostic Accuracy and Interobserver Agreement in Readers with Different Expertise 64
Contemporary Pathological Stage Distribution After Radical Prostatectomy in North American High-Risk Prostate Cancer Patients 64
Small renal masses initially managed using Active surveillance: Results from a retrospective study with long-term follow-up 64
Predictive factors of overall and major postoperative complications after partial nephrectomy: Results from a multicenter prospective study (The RECORd 1 project) 64
How does 68Ga-prostate-specific membrane antigen positron emission tomography/computed tomography impact the management of patients with prostate cancer recurrence after surgery? 64
Expanding utilization of robotic partial nephrectomy for clinical T1b and complex T1a renal masses 63
Massive hematuria due to ruptured iatrogenic aortic pseudoaneurysm: A case report 63
Changes in renal function after nephroureterectomy for upper urinary tract carcinoma: analysis of a large multicenter cohort (Radical Nephroureterectomy Outcomes (RaNeO) Research Consortium) 62
Life expectancy in metastatic urothelial bladder cancer patients according to race/ethnicity 62
The biopsy Gleason score 3+4 in a single core does not necessarily reflect an unfavourable pathological disease after radical prostatectomy in comparison with biopsy Gleason score 3+3: Looking for larger selection criteria for active surveillance candidates 62
Retroperitoneal Robot-Assisted Versus Open Partial Nephrectomy for cT1 Renal Tumors: A Matched-Pair Comparison of Perioperative and Early Oncological Outcomes 62
Racial/ethnic disparities in the distribution and effect of type and number of high-risk criteria on mortality in prostate cancer patients treated with radiotherapy 61
The Prognostic Role of Circulating Tumor Cells (CTC) in High-risk Non–muscle-invasive Bladder Cancer 61
Preservation of the smooth muscular internal (vesical) sphincter and of the proximal urethra for the early recovery of urinary continence after retropubic radical prostatectomy: a prospective case-control study 61
Sexuality during COVID lockdown: a cross-sectional Italian study among hospital workers and their relatives 61
Predictive clinico-pathological factors to identify BCG, unresponsive patients, after re-resection for T1 high grade non-muscle invasive bladder cancer 60
The Prognostic Impact of Tumor Size on Cancer-Specific and Overall Survival among Patients with Pathologic T3a Renal Cell Carcinoma 60
State of the art of PET/CT with 11-choline and 18F-fluorocholine in the diagnosis and follow-up of localized and locally advanced prostate cancer 60
Retroperitoneal approach for robot-assisted partial nephrectomy: Technique and early outcomes 60
Modified Glasgow Prognostic Score as a Predictor of Recurrence in Patients with High Grade Non-Muscle Invasive Bladder Cancer Undergoing Intravesical Bacillus Calmette–Guerin Immunotherapy 60
Peri-Operative Outcomes after Open and Robot-Assisted Radical Cystectomy by Using an Advanced Bipolar Seal and Cut Technology (Caiman®): A Prospective, Comparative, and Multi-Institutional Study 59
Differing risk of cancer death among patients with pathologic t3a renal cell carcinoma: Identification of risk categories according to fat infiltration and renal vein thrombosis 59
Surveillance for small renal masses: Retrospective analysis of a cohort of 42 patients with long-term follow-up 59
Adenocarcinoma of the Bladder: Assessment of Survival Advantage Associated With Radical Cystectomy and Comparison With Urothelial Bladder Cancer 58
Immediate radical cystectomy versus BCG immunotherapy for T1 high-grade non-muscle-invasive squamous bladder cancer: an international multi-centre collaboration 58
Predictors of positive surgical margins after nephron-sparing surgery for renal cell carcinoma: retrospective analysis on 298 consecutive patients [Fattori predittivi di margini chirurgici positivi dopo chirurgia conservativa per neoplasia renale: analisi retrospettiva monocentrica su 298 pazienti] 58
Re: Impact of complete bladder neck preservation on urinary continence, quality of life and surgical margins after radical prostatectomy: A randomized, controlled, single blind trial 58
Positron-emission tomography in imaging and staging prostate cancer 58
State-of-the-art imaging techniques in the management of preoperative staging and re-staging of prostate cancer 58
Three-dimensional digital reconstruction of renal model to guide preoperative planning of robot-assisted partial nephrectomy 58
Positive surgical margins after nephron-sparing surgery for renal cell carcinoma: Incidence, clinical impact, and management 58
Warm ischemia time and postoperative complications after partial nephrectomy for renal cell carcinoma [Tiempo de isquemia caliente y complicaciones postoperatorias después de la nefrectomía parcial por carcinoma de células renales] 57
Molecular diagnostic tools for the detection of nodal micrometastases in prostate cancer patients undergoing radical prostatectomy with extended pelvic lymph node dissection: a prospective study 57
Is Fast Track protocol a safe tool to reduce hospitalization time after radical cystectomy with ileal urinary diversion? Initial results from a single high-volume centre 57
Preoperative Staging With 11C-Choline PET/CT Is Adequately Accurate in Patients With Very High-Risk Prostate Cancer 56
Totale 7.684
Categoria #
all - tutte 56.649
article - articoli 56.649
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 113.298


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.226 37 45 2 21 73 114 30 445 42 84 12 321
2022/2023946 147 54 10 72 74 110 6 114 233 13 94 19
2023/2024648 28 73 13 115 53 88 45 17 10 38 38 130
2024/20252.268 67 182 19 67 376 333 156 275 93 123 267 310
2025/20264.004 525 116 210 199 456 365 590 262 314 340 288 339
2026/2027411 411 0 0 0 0 0 0 0 0 0 0 0
Totale 10.741